Literature DB >> 30713873

Anti-NMDA Receptor Encephalitis with a Favorable Prognosis Despite Delayed Treatment Due to Longstanding Psychiatric Symptoms.

Seung Woo Kim1, Hyung Seok Lee1, Phil Hyu Lee1, Sun-Ah Choi2.   

Abstract

Entities:  

Keywords:  anti‐N‐methyl‐D‐aspartate receptor encephalitis; delayed diagnosis; psychiatric symptoms

Year:  2014        PMID： 30713873      PMCID： PMC6353437          DOI： 10.1002/mdc3.12095

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  9 in total

1.  Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis mimicking a primary psychiatric disorder in an adolescent.

Authors:  Sébastien Lebon; Claire Mayor-Dubois; Irina Popea; Claudia Poloni; Nalini Selvadoray; Alain Gumy; Eliane Roulet-Perez
Journal:  J Child Neurol       Date:  2012-03-08       Impact factor: 1.987

2.  A subacute behavioral disorder in a female adolescent. Autoimmune anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

Authors:  André R De Nayer; Nathalie Myant; Christian J M Sindic
Journal:  Biol Psychiatry       Date:  2009-06-17       Impact factor: 13.382

3.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

4.  Reversible paraneoplastic encephalitis in three patients with ovarian neoplasms.

Authors:  Janos L Tanyi; Evelyn B Marsh; Josep Dalmau; Christina S Chu
Journal:  Acta Obstet Gynecol Scand       Date:  2012-03-05       Impact factor: 3.636

Review 5.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

Review 6.  NMDA receptor antibody encephalitis.

Authors:  Sarosh R Irani; Angela Vincent
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

7.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

8.  N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

Authors:  Sarosh R Irani; Katarzyna Bera; Patrick Waters; Luigi Zuliani; Susan Maxwell; Michael S Zandi; Manuel A Friese; Ian Galea; Dimitri M Kullmann; David Beeson; Bethan Lang; Christian G Bien; Angela Vincent
Journal:  Brain       Date:  2010-06       Impact factor: 13.501

9.  Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis.

Authors:  Matthew S Kayser; Maarten J Titulaer; Núria Gresa-Arribas; Josep Dalmau
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.